Article Text

Download PDFPDF

Does increased aromatase activity in adipose fibroblasts cause low sexual desire in patients with HIV lipodystrophy?
  1. D Goldmeier,
  2. G Scullard,
  3. M Kapembwa,
  4. H Lamba,
  5. G Frize
  1. Jefferiss Wing, St Mary's Hospital, London W2 1NY, UK
  1. Correspondence to:
 Dr Goldmeier, Jefferiss Wing, St Mary's Hospital, London W2 1NY, UK

Abstract

There is evidence from our own unit and other workers that many patients who have lipodystrophy on HAART given for HIV disease also have raised oestrogen levels and complain of low sexual desire. This hypothesis paper discusses a possible pathological mechanism for these changes—an increase in the number of fibroblasts and macrophages present in lipoatrophic areas that could convert testosterone to oestrogen by intracellular aromatisation. This process is known to be enhanced by increased levels of tumour necrosis factor, interleukin 6 (IL-6), and hydroxycorticosteroids present in many patients with HIV lipodystrophy. Treatment options are discussed, including aromatase inhibitors and testosterone.

  • lipodystrophy
  • oestrogen
  • sexual desire
  • HIV
  • HAART, highly active antiretroviral therapy
  • IL, interleukin
  • PI, protease inhibitors
  • SHBG, sex hormone binding globulin
  • TNF, tumour necrosis factor
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.